Search for: "U.S. Compounding Inc." Results 21 - 40 of 871
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Feb 2013, 4:00 pm by Amber Walsh
Also in December, Galera Therapeutics, Inc., announced an $11 million series A venture capital financing. [read post]
13 May 2009, 9:50 pm
By Donald Zuhn -- The Federal Circuit today affirmed a determination by the District Court for the District of Delaware that U.S. [read post]
14 Jun 2019, 4:34 pm by Ben Vernia
According to DOJ’s press release: The Department of Justice announced today that the United States has filed a complaint in intervention against Smart Pharmacy Inc., and SP2 LLC, two compounding pharmacies located in Jacksonville, Florida. [read post]
28 Mar 2014, 5:33 pm
   Procedural History"Defendants-Appellants Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries, Ltd.; Lupin, Ltd.; Lupin Pharmaceuticals, Inc.; Actavis, Inc.; Actavis Elizabeth, LLC; Cobalt Laboratories, Inc.; Cobalt Pharmaceuticals, Inc.; Sun Pharma Global, Inc; Sun Pharmaceutical Industries, Ltd.; Sun Pharmaceutical Industries, Inc.; Wockhardt Ltd.; and Mylan Pharmaceuticals, Inc. [read post]
5 Oct 2022, 8:12 pm by Patent Docs
Patent No. 7,326,708 were either anticipated or rendered obvious by the asserted prior art, in Mylan Pharmaceuticals Inc. v. [read post]
14 Feb 2010, 8:47 pm by Patent Docs
By James DeGiulio -- Last week, NexBio, Inc. announced the issuance of U.S. [read post]
25 Jan 2017, 10:20 am by Green and Associates
The Jenkins admitted that AMS, after July of 2007, at the direction of Larry Jenkins, continued to compound inhalation drugs but billed Medicare for reimbursement as if they were non-compounded drugs.Annie Jenkins, the compliance officer, admitted she knew of the false statements being made, failed to notify the appropriate authorities, and took affirmative action to conceal the fraudulent billing.Larry and Annie Jenkins will be sentenced on March 7, 2017, at 10:00 a.m. by… [read post]
25 Jan 2017, 10:20 am by Green and Associates
The Jenkins admitted that AMS, after July of 2007, at the direction of Larry Jenkins, continued to compound inhalation drugs but billed Medicare for reimbursement as if they were non-compounded drugs.Annie Jenkins, the compliance officer, admitted she knew of the false statements being made, failed to notify the appropriate authorities, and took affirmative action to conceal the fraudulent billing.Larry and Annie Jenkins will be sentenced on March 7, 2017, at 10:00 a.m. by… [read post]
13 May 2016, 8:02 am by Eric Needs
Food and Drug Administration officials posted online last week was directed to an Alabama drug compounder called Medaus Pharmacy Inc. [read post]
7 May 2016, 11:35 am by Immigration Prof
Guest blogger: Gabriela Garcia, first-year law student, University of San Francisco The Supreme Court’s decision on the Hoffman Plastic Compounds, Inc. v. [read post]